Penn Medicine
HAVERFORD, Pennsylvania, United States
Dr. Naomi Haas is medical oncologist with a broad background in patient care and basic science training applied to clinical trial development. She is the leader of the prostate cancer and kidney cancer medical oncology clinical research programs at the Abramson Cancer Center at the University of Pennsylvania. Early in her career at the Fox Chase Cancer Center, she was supported by a NIH postdoctoral training grant, a NIH K08 Clinical Investigator award and an ACS Institutional grant in the fields of transcriptional regulation. This background in basic science informed her efforts in clinical trial development. She is passionate about her care of patients, and she has led multiple investigator-initiated trials in kidney and prostate cancer. She was the national study chair of ASSURE and has helped in the development of EVEREST, Keynote-564, PROSPER and the PROTECT adjuvant trials for kidney cancer.
Disclosure information not submitted.